These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27620172)

  • 21. Design, synthesis and bioactivity of novel naphthalimide-benzotriazole conjugates against A549 cells via targeting BCL2 G-quadruplex and inducing autophagy.
    Wang X; Zhang M; Xiong XQ; Yang H; Wang P; Zhang K; Awadasseid A; Narva S; Wu YL; Zhang W
    Life Sci; 2022 Aug; 302():120651. PubMed ID: 35597548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclometalated ruthenium (II) complexes induced HeLa cell apoptosis through intracellular reductive injury.
    Zhu X; Sun Q; Guo X; Liang C; Zhang Y; Huang W; Pei W; Huang Z; Chen L; Chen J
    J Inorg Biochem; 2023 Oct; 247():112333. PubMed ID: 37480763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of substituents on the ability of nickel Schiff base complexes with four pendant groups to bind to G-quadruplexes.
    Assadawi N; Ferderer M; Kusi-Appauh N; Yu H; Dillon CT; Sluyter R; Richardson C; Ralph SF
    Dalton Trans; 2024 Jul; 53(30):12720-12739. PubMed ID: 39017709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticancer Potential of Dendritic Poly(aryl ether)-Substituted Polypyridyl Ligand-Based Ruthenium(II) Coordination Entities.
    Raju L; Javan Nikkhah S; K M; Vandichel M; Eswaran R
    ACS Appl Bio Mater; 2023 Oct; 6(10):4226-4239. PubMed ID: 37782900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on apoptosis induced by B-norcholesteryl benzimidazole compounds in HeLa cells.
    Huang X; Wu Y; Huang Y; Liu Q; Chen H; Dai F; Liang F; Gan C
    Steroids; 2021 Apr; 168():108802. PubMed ID: 33587927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are Zn(II) pincer complexes efficient apoptosis inducers? a deep insight into their activity against A549 lung cancer cells.
    Das A; Sankaralingam M
    Dalton Trans; 2023 Oct; 52(40):14465-14476. PubMed ID: 37772631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Cyclometalated Ruthenium(II) Complex Induces Oncosis for Synergistic Activation of Innate and Adaptive Immunity.
    Feng T; Tang Z; Shu J; Wu X; Jiang H; Chen Z; Chen Y; Ji L; Chao H
    Angew Chem Int Ed Engl; 2024 Jul; 63(31):e202405679. PubMed ID: 38771671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-assembly of c-myc DNA promoted by a single enantiomer ruthenium complex as a potential nuclear targeting gene carrier.
    Wu Q; Mei W; Zheng K; Ding Y
    Sci Rep; 2016 Jul; 6():28582. PubMed ID: 27381008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AIMing towards improved antitumor efficacy.
    Weaver MJ; Kearns AK; Stump S; Li C; Gajewski MP; Rider KC; Backos DS; Reigan PR; Beall HD; Natale NR
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1765-1770. PubMed ID: 25782743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tracking Plasma Membrane Damage Using a Ruthenium(II) Complex Phosphorescent Indicator Paired with Cholesterol.
    Fa Q; Gao X; Zhang W; Ren J; Song B; Yuan J
    Inorg Chem; 2024 Jun; 63(22):10443-10451. PubMed ID: 38774973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the mitochondrial VDAC in hepatocellular carcinoma using a polyclonal antibody-conjugated to a nitrosyl ruthenium complex.
    Ramos LCB; Rodrigues FP; Biazzotto JC; de Paula Machado S; Slep LD; Hamblin MR; da Silva RS
    J Biol Inorg Chem; 2018 Aug; 23(6):903-916. PubMed ID: 29971501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chiral SPINOL-Based Pt(II) Metallacycles For Immunogenic Cell Death.
    Zhu L; Du W; Li Y; Li D; Wei W; Zhao J; Wang X
    Inorg Chem; 2023 Sep; 62(37):14922-14930. PubMed ID: 37674254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of new G-quadruplex binding chemotypes.
    Ohnmacht SA; Varavipour E; Nanjunda R; Pazitna I; Di Vita G; Gunaratnam M; Kumar A; Ismail MA; Boykin DW; Wilson WD; Neidle S
    Chem Commun (Camb); 2014 Jan; 50(8):960-3. PubMed ID: 24302123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bimetallic Cu@Ru Core-Shell Structures with Ligand Effects for Endo-Exogenous Stimulation-Mediated Dynamic Oncotherapy.
    Zheng N; Hu X; Yan L; Ding LY; Feng J; Li D; Ji T; Ai F; Yu K; Hu J
    Nano Lett; 2024 May; 24(20):6165-6173. PubMed ID: 38717317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent and orthogonal gold(I) and ruthenium(II) catalysis inside living cells.
    Vidal C; Tomás-Gamasa M; Destito P; López F; Mascareñas JL
    Nat Commun; 2018 May; 9(1):1913. PubMed ID: 29765051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting Mitochondrial Guanine Quadruplexes for Photoactivatable Chemotherapy in Normoxic and Hypoxic Environments.
    Keyes TE; Holden L; Curley RC; Avella G; Long C
    Angew Chem Int Ed Engl; 2024 Jul; ():e202408581. PubMed ID: 39012206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Ru(II)-Strained Complex with 2,9-Diphenyl-1,10-phenanthroline Ligand Induces Selective Photoactivatable Chemotherapeutic Activity on Human Alveolar Carcinoma Cells via Apoptosis.
    Mansour N; Mehanna S; Bodman-Smith K; Daher CF; Khnayzer RS
    Pharmaceuticals (Basel); 2023 Dec; 17(1):. PubMed ID: 38256884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms.
    Hildebrandt J; Häfner N; Kritsch D; Görls H; Dürst M; Runnebaum IB; Weigand W
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Designing Aptamer-Gold Nanoparticle-Loaded pH-Sensitive Liposomes Encapsulate Morin for Treating Cancer.
    Ding X; Yin C; Zhang W; Sun Y; Zhang Z; Yang E; Sun D; Wang W
    Nanoscale Res Lett; 2020 Mar; 15(1):68. PubMed ID: 32232589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ruthenium(II) complexes with 6-methyl-2-thiouracil selectively reduce cell proliferation, cause DNA double-strand break and trigger caspase-mediated apoptosis through JNK/p38 pathways in human acute promyelocytic leukemia cells.
    Bomfim LM; de Araujo FA; Dias RB; Sales CBS; Rocha CAG; Correa RS; Soares MBP; Batista AA; Bezerra DP
    Sci Rep; 2019 Aug; 9(1):11483. PubMed ID: 31391500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.